Stigma, Social Cohesion, and HIV Risk Among Sexual and Gender Minorities in Two Cities in Zimbabwe.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Sep 2022
Historique:
accepted: 09 02 2022
pubmed: 20 3 2022
medline: 16 8 2022
entrez: 19 3 2022
Statut: ppublish

Résumé

Though stigma is a recognized contributor to the disproportionate HIV burden among sexual and gender minorities (SGM) in sub-Saharan Africa, data describing this association among Zimbabwean SGM are limited. We examined relationships between SGM stigma and HIV and the potential for social cohesion to moderate the association among Zimbabwean men who have sex with men, transgender women, and genderqueer individuals. Consenting participants (n = 1511) recruited through respondent-driven sampling for a biobehavioral survey in Harare and Bulawayo completed structured interviews and received HIV testing. Reported SGM stigma was common (68.9% in Harare and 65.3% in Bulawayo) and associated with HIV infection in Harare (adjusted prevalence ratio [aPR] = 1.82, 95% confidence interval [CI] = 1.27-2.62) and Bulawayo (aPR = 1.51, 95% CI = 1.15-2.00) in relative risk regression. Social cohesion did not moderate these relationships. Findings demonstrate stigma's association with HIV vulnerability among Zimbabwean SGM, highlighting the need for stigma-mitigation to reduce HIV transmission in this population.

Identifiants

pubmed: 35304904
doi: 10.1007/s10461-022-03622-8
pii: 10.1007/s10461-022-03622-8
pmc: PMC9372004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2994-3007

Subventions

Organisme : U.S. president's emergency plan for aids relief
ID : NU2GGH00193

Informations de copyright

© 2022. The Author(s).

Références

AIDS Behav. 2020 Jan;24(1):29-38
pubmed: 31587116
AIDS Care. 2016;28(6):795-804
pubmed: 26824888
PLoS One. 2014 Jan 31;9(1):e87527
pubmed: 24498125
Ann Epidemiol. 2020 Feb;42:25-32
pubmed: 31902624
Soc Sci Med. 2008 May;66(9):1999-2010
pubmed: 18299168
BMC Med Res Methodol. 2012 Feb 15;12:14
pubmed: 22335836
Lancet. 2012 Jul 28;380(9839):388-99
pubmed: 22819659
Cult Health Sex. 2020 Nov;22(11):1269-1281
pubmed: 31661668
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S52-S59
pubmed: 27930612
AIDS Behav. 2015 Aug;19(8):1460-9
pubmed: 25969182
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
Arch Sex Behav. 2006 Jun;35(3):327-45
pubmed: 16799837
BMC Public Health. 2019 Dec 4;19(1):1634
pubmed: 31801503
AIDS Behav. 2013 May;17(4):1442-53
pubmed: 22569942
BMC Public Health. 2011 Oct 05;11:766
pubmed: 21975248
Curr Opin HIV AIDS. 2014 Mar;9(2):168-73
pubmed: 24322537
AIDS. 2006 Mar 21;20(5):731-9
pubmed: 16514304
AIDS Care. 2014;26(7):882-9
pubmed: 24295155
Lancet. 2012 Jul 28;380(9839):439-45
pubmed: 22819652
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18715
pubmed: 24242263
Sex Transm Infect. 2001 Apr;77(2):84-92
pubmed: 11287683
J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S189-97
pubmed: 25723984
PLoS Med. 2017 Nov 7;14(11):e1002422
pubmed: 29112689
Curr Opin HIV AIDS. 2014 Mar;9(2):156-67
pubmed: 24445371
Lancet HIV. 2022 Mar;9(3):e182-e201
pubmed: 35150606
J Int AIDS Soc. 2016 Jul 17;19(3 Suppl 2):20774
pubmed: 27431465
Sex Transm Infect. 2018 Aug;94(5):331-333
pubmed: 28062734
PLoS One. 2012;7(5):e38143
pubmed: 22693590
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Health Psychol. 2008 Jul;27(4):455-62
pubmed: 18643003
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25131
pubmed: 30033563
PLoS One. 2011;6(12):e28760
pubmed: 22194906
Stat Methods Med Res. 1999 Mar;8(1):3-15
pubmed: 10347857
Lancet. 2012 Jul 28;380(9839):367-77
pubmed: 22819660
Lancet. 2009 Aug 1;374(9687):416-22
pubmed: 19616840
AIDS Care. 2020 Aug;32(8):1052-1060
pubmed: 32500722
AIDS Behav. 2011 Aug;15(6):1088-97
pubmed: 21153432
Health SA. 2021 Apr 22;26:1462
pubmed: 34007471
J Int AIDS Soc. 2013 Dec 02;16 Suppl 3:18749
pubmed: 24321112
J Int AIDS Soc. 2015 Oct 21;18:20226
pubmed: 26493863

Auteurs

Sophia S Miller (SS)

ICAP at Columbia University, New York, NY, USA. sm4594@cumc.columbia.edu.

Joanne E Mantell (JE)

HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, Division of Gender, Sexuality and Health, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.

Lauren E Parmley (LE)

ICAP at Columbia University, New York, NY, USA.

Godfrey Musuka (G)

ICAP at Columbia University, New York, NY, USA.

Innocent Chingombe (I)

ICAP at Columbia University, New York, NY, USA.

Munyaradzi Mapingure (M)

ICAP at Columbia University, New York, NY, USA.

John H Rogers (JH)

Division of Global HIV and TB, Center for Global Health, U.S. Centers for Disease Control and Prevention, Harare, Zimbabwe.

Yingfeng Wu (Y)

ICAP at Columbia University, New York, NY, USA.

Avi J Hakim (AJ)

Division of Global HIV and TB, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Owen Mugurungi (O)

AIDS and TB Programme, Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe.

Chesterfield Samba (C)

GALZ, Harare, Zimbabwe.

Tiffany G Harris (TG)

ICAP at Columbia University, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH